These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 656294)

  • 1. Bronchodilator effect of delta1-tetrahydrocannabinol.
    Hartley JP; Nogrady SG; Seaton A
    Br J Clin Pharmacol; 1978 Jun; 5(6):523-5. PubMed ID: 656294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients.
    Williams SJ; Hartley JP; Graham JD
    Thorax; 1976 Dec; 31(6):720-3. PubMed ID: 797044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilatation after inhalation of the antihistamine clemastine.
    Nogrady SG; Hartley JP; Handslip PD; Hurst NP
    Thorax; 1978 Aug; 33(4):479-82. PubMed ID: 694800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metered dose inhaler salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels.
    Rodrigo G; Rodrigo C
    Am J Emerg Med; 1996 Mar; 14(2):144-50. PubMed ID: 8924135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma.
    Phillips K; Oborne J; Harrison TW; Tattersfield AE
    Thorax; 2004 Jan; 59(1):21-5. PubMed ID: 14694241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of oral delta-1-(trans)-tetrahydrocannabinol in reversible airways obstruction.
    Davies BH; Radcliffe S; Seaton A; Graham JD
    Thorax; 1975 Feb; 30(1):80-5. PubMed ID: 1124532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between symptoms and objective measures of airway obstruction in asthmatic patients.
    Liam CK; Goh CT; Isahak M; Lim KH; Wong CM
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):79-83. PubMed ID: 11699724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilatation effects of a small volume spacer used with a metered-dose inhaler.
    Liu CL; Lu YT
    J Asthma; 2009 Sep; 46(7):637-41. PubMed ID: 19728196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhalation characteristics of patients when they use different dry powder inhalers.
    Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary function in symptom-free asthmatics.
    Yaacob I; Mohammad M
    Singapore Med J; 1993 Dec; 34(6):522-3. PubMed ID: 8153715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG; Earnshaw JS; Palmer JB
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
    Wallin A; Sandström T; Rosenhall L; Melander B
    Thorax; 1993 Jun; 48(6):611-4. PubMed ID: 8346490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of a powder inhaler (Turbuhaler) in moderate asthmatic crises in children].
    Rufin P; Benoist MR; Panqueva P; Brouard JJ; De Blic J; Scheinmann P
    Rev Mal Respir; 1993; 10(6):545-50. PubMed ID: 8122021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator response in pulmonary disease at two different states of respiratory mechanics.
    Ahmad HR; Rayani HH; Vellani CW; Khan MA; Zaidi SR
    Respiration; 1996; 63(5):288-91. PubMed ID: 8885001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous injection of salbutamol in asthma.
    May CS; Paterson JW; Spiro SG; Johnson AJ
    Br J Clin Pharmacol; 1975 Dec; 2(6):495-501. PubMed ID: 1234013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
    Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator effects of exercise hyperpnea and albuterol in mild-to-moderate asthma.
    Milanese M; Saporiti R; Bartolini S; Pellegrino R; Baroffio M; Brusasco V; Crimi E
    J Appl Physiol (1985); 2009 Aug; 107(2):494-9. PubMed ID: 19541736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.